Outcome of Patients with Severe CombinedImmunodeficiency/ Combined Immunodeficiencydue to ADA Deficiency

ÇAĞDAŞ AYVAZ D. N., GÜR ÇETİNKAYA P., KARAATMACA b., ESENBOĞA S., TAN Ç., YILMAZ T., ...More

The 44th Annual Meeting of the European Society for Blood andMarrow Transplantation: Physicians Poster Sessions, LİZBON, Portugal, 18 - 21 March 2018, (Summary Text) identifier identifier identifier identifier

  • Publication Type: Conference Paper / Summary Text
  • Doi Number: 10.1007/s10875-015-0191-z
  • City: LİZBON
  • Country: Portugal
  • Keywords: Adenosine deaminase deficiency, allogeneic haematopoietic stem cell transplantation, enzyme replacement therapy with PEG-ADA, ADENOSINE-DEAMINASE DEFICIENCY, STEM-CELL TRANSPLANTATION, COMBINED IMMUNODEFICIENCY DISEASE, BONE-MARROW-TRANSPLANTATION, IMMUNE RECONSTITUTION, DELAYED-ONSET, SCID PATIENTS, GENE-THERAPY, MUTATIONS, GENOTYPE
  • Hacettepe University Affiliated: Yes